Extracorporeal Membrane Oxygenator (ECMO) is a surrogate lung or heart that can be used in patients who suffer from heart or lung failure. The first reported adult ECMO case was in the year 1972, and first neonate ECMO case in 1975. This technology was used in children with heart disease or lung failure for many years in the western countries.
It was accepted as a treatment modality for adult patients after the 2003 Swine Flu pandemic, and its use became more global with more Asia Pacific countries utilizing ECMO for severe viral lung failure. In India, the use of ECMO was limited to cardiac surgery patients, and it was largely unknown as a life-saving option to the general population.
During the COVID10 pandemic, as the lung failures were severe and ventilators were not able to achieve gas exchange, ECMO emerged as a sought-after treatment modality. However, as the technology was new to India, the number of providers with expertise as well as number of hospitals with the infrastructure and equipment were limited.
ECMO ADOPTION PREREQUISITES
ECMO is costly, resource intensive, and needs skilled manpower. ECMO needs a multidisciplinary team effort, advanced diagnostics, trained nursing, special equipment and specifically designed ICU cubicles.
This infrastructure is usually present in cardiac and transplant centers. Patients admitted under adult or pediatric critical care, for both—cardiac surgery and/or for medical management of shock or respiratory failure—may benefit from ECMO.
هذه القصة مأخوذة من طبعة March 2024 من Healthcare Radius.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك ? تسجيل الدخول
هذه القصة مأخوذة من طبعة March 2024 من Healthcare Radius.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك? تسجيل الدخول
ADDRESSING INDIA'S RURAL CARE GAP
Lakhs of rural Indians lack access to healthcare services. Learn the ways India can improve healthcare accessibility in its rural areas.
iMeUsWe unveils at-home DNA testing services
iMeUsWe and MapMyGenome's at-home DNA testing to offer health and ancestry insights.
CAR T-CELL THERAPY: A PROMISING CANCER TREATMENT ADVANCEMENT
Employing genetically modified immune cells to attack tumors, CAR T-cell therapy offers new hope for cancer patients.
LEADING WITH INNOVATION
\"Every regional market presents a unique set of challenges and opportunities,\" said Ms Zahabiya Khorakiwala, Managing Director, Wockhardt Hospitals Group, during Healthcare Radius Leadership Vidcast.
OVERCOMING INDIA'S AMR CHALLENGE
India faces a growing threat of antimicrobial resistance (AMR). Experts warn of superbugs and ineffective treatments. Is there hope? Read on to find out.
SOCC launches online second opinion for pediatric care
SOCC’s online second opinion consultations for pediatric care aims to bridge the gap in pediatric healthcare services in India.
Clove Dental opens 12 clinics in a single day
Clove Dental marks its 13th anniversary with nationwide expansion. Get full details.
BM Birla Heart Hospital launches cardiac care program
BM Birla Heart Hospital partners with Dozee for Al-powered cardiac care program.
PD Hinduja Hospital goes digital for infection control
Ropes in Ibhar Technologies for infection control, patient safety, and auditing automation.
Maruti Suzuki marks one year of cardiac care in rural Gujarat
Maruti Suzuki celebrates one year of providing advanced cardiac care in rural Gujarat.